ARTICLE | Company News
Marshall Edwards, Novogen deal
May 16, 2011 7:00 AM UTC
Marshall Edwards completed its previously announced acquisition of all IP related to Novogen's isoflavone-related platform for 1,000 shares of Marshall Edwards convertible preferred stock following ap...